pillbase.ru

Trazec

Active substance: nateglinide

nateglinide

Centralised EU authorisationActive

Marketing holder: Novartis Europharm Ltd.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 18
  • NATEGLINIDE
    TABLET · NATEGLINIDE 120 mg/1
    16571-759
    Rising Pharma Holdings, Inc.
  • NATEGLINIDE
    TABLET · NATEGLINIDE 60 mg/1
    16571-758
    Rising Pharma Holdings, Inc.
  • Nateglinide
    TABLET · NATEGLINIDE 120 mg/1
    51407-657
    Golden State Medical Supply, Inc.
  • Nateglinide
    TABLET, COATED · NATEGLINIDE 120 mg/1
    71209-031
    Cadila Pharmaceuticals Limited
  • Nateglinide
    TABLET · NATEGLINIDE 60 mg/1
    51407-656
    Golden State Medical Supply, Inc.
All products in this country (18)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4a87-7126-b262-f19b07ef6ab1,01a1208d-3656-7863-8673-f0d55b3158fc,01a1208d-acb9-70d3-b846-511c6f95220e,01a1208e-0731-798c-b766-ae29d171e51e,01a1208e-6793-765d-878e-d38f62c0a78d;count=18 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/000383
Registration status
Active
ATC code
A10BX03
Sources
  • product · EMA · EMEA/H/C/000383 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/000383 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/000383 · Verified 2026-10-09